Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00378950 · ClinicalTrials.gov registry record · NA
Educational Program for Various Health Literacy Levels to Improve the Health of Individuals With Heart Failure
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 605
- Enrollment target
NCT00378950: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT00378950 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 605 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00378950, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 605 participants
- Enrollment target
Study Summary
Heart failure (HF) affects 5 million people in the United States. Health literacy, which is the ability to read and comprehend important medical information, plays an important role in the health of individuals with HF. This study will evaluate the effectiveness of an educational program developed for various levels of health literacy at improving medical outcomes and quality of life in individuals with HF.
Interventions
- BEHAVIORAL Teach to Goal (TTG)
- BEHAVIORAL Brief Educational Intervention (BEI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 605 participants |
| Start Date | 2007-03 |
| Est. Completion | 2011-02 |
| Phase | NA |
What the finished NCT00378950 record still lists
NCT00378950 is an interventional study that assigns participants to a tested intervention. The registered 605 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 2 interventions - of which Teach to Goal (TTG) is the first listed.
NCT00378950 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00378950 about?
NCT00378950 is a clinical study titled "Educational Program for Various Health Literacy Levels to Improve the Health of Individuals With Heart Failure". Heart failure (HF) affects 5 million people in the United States. Health literacy, which is the ability to read and comprehend important medical information, plays an important role in the health of individuals with HF. This study will evaluate the effectiveness of an educational program developed f...
What is the current status of trial NCT00378950?
This trial is currently completed. It is a NA study. The enrollment target is 605 participants. The study started on 2007-03. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00378950?
The interventions under investigation include: Teach to Goal (TTG) (BEHAVIORAL), Brief Educational Intervention (BEI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00378950?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00378950's enrollment target sits among peer trials
605 162nd of 2000 higher than 1,839 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02342444 · 606 participants · Phase 4
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
- NCT03849443 · 604 participants · Early Phase 1
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery
- NCT05238922 · 604 participants · Phase 1
Study of INCB123667 in Subjects With Advanced Solid Tumors
- NCT06040541 · 604 participants · Phase 1
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia